相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association Between Symptomatic Versus Asymptomatic Recurrence and Survival in Bladder Cancer
Chelsea K. Osterman et al.
CLINICAL GENITOURINARY CANCER (2018)
A Real-World Data Study to Evaluate Treatment Patterns, Clinical Characteristics and Survival Outcomes for First-and Second-Line Treatment in Locally Advanced and Metastatic Urothelial Cancer Patients in Germany
Guenter Niegisch et al.
JOURNAL OF CANCER (2018)
Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United States
Matthew D. Galsky et al.
BLADDER CANCER (2018)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
J. Bellmunt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Urothelial carcinoma management in elderly or unfit patients
Joaquim Bellmunt et al.
EJC SUPPLEMENTS (2016)
Perioperative treatment and radical cystectomy for bladder cancer - a population based trend analysis of 10,338 patients in the Netherlands
Tom J. N. Hermans et al.
EUROPEAN JOURNAL OF CANCER (2016)
Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1?
Homayoun Zargar et al.
JOURNAL OF UROLOGY (2016)
Standardizing Patient Outcomes Measurement
Michael E. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer
Neil E. Martin et al.
EUROPEAN UROLOGY (2015)
Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach
Alicia K. Morgans et al.
EUROPEAN UROLOGY (2015)
Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing Tides
Zachary D. Reardon et al.
EUROPEAN UROLOGY (2015)
Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone
Laura S. Mertens et al.
BJU INTERNATIONAL (2014)
Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base
Angela B. Smith et al.
BJU INTERNATIONAL (2014)
Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy
Matthew D. Galsky et al.
CANCER (2013)
Response to induction chemotherapy and surgery in non-organ confined bladder cancer: A single institution experience
R. P. Meijer et al.
EJSO (2013)
Use of Potentially Curative Therapies for Muscle-invasive Bladder Cancer in the United States: Results from the National Cancer Data Base
Phillip J. Gray et al.
EUROPEAN UROLOGY (2013)
Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer
Toni K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986
Maria De Santis et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987
Joaquim Bellmunt et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Neoadjuvant Chemotherapy for Invasive Bladder Cancer
Guru Sonpavde et al.
CURRENT UROLOGY REPORTS (2012)
EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors
A. G. Pallis et al.
ANNALS OF ONCOLOGY (2011)
Exclusion of Older People from Clinical Trials Professional Views from Nine European Countries Participating in the PREDICT Study
Peter Crome et al.
DRUGS & AGING (2011)
International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
Gareth Griffiths
JOURNAL OF CLINICAL ONCOLOGY (2011)
A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy
Matthew D. Galsky et al.
LANCET ONCOLOGY (2011)
Long-term-survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer (vol 17, pg v118, 2006)
Hans von der Maase et al.
ANNALS OF ONCOLOGY (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Second-Line Chemotherapy for Advanced Urothelial Cancer: Because We Should or Because We Can?
Robert Dreicer
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract
Joaquim Bellmunt et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium:: Results of a randomized phase 2 trial
Luigi Dogliotti et al.
EUROPEAN UROLOGY (2007)
Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder
Atreya Dash et al.
CANCER (2006)
Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data
H Abol-Enein et al.
EUROPEAN UROLOGY (2005)
Long-term-survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer
H von der Maase et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
HB Grossman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract -: An alternative therapy
M Nogué-Aliguer et al.
CANCER (2003)
分享论文
